October 15th 2025
Merck reveals promising phase 3 results for DOR/ISL, showing minimal impact on weight and lipids in adults with suppressed HIV-1.
September 29th 2025
September 25th 2025
Emerging Infections: What You Need to Know, Part 2
November 1st 2007Fear of bioterrorism persists because of new reports of biological warfare, including the most recent attack that involved a Russian spy who was poisoned with polonium-210. However, vaccination against potential biological weapons, such as anthrax and smallpox, is controversial because of associated adverse effects.
Secondary Syphilis and HIV Positivity
November 1st 2007Six months after testing positive for HIV in 10 bands, a 24-year-old homosexual man presented with a macular rash on his palms and soles. He first noticed the lesions 2 weeks earlier; they were not pruritic or painful. He also had a brighter, more inflamed rash in the groin and antecubital fossae that was presumed to be a yeast infection and was treated with fluconazole. He had no other symptoms.
FDA Approves First-in-Class Integrase Inhibitor for Treatment-Resistant HIV-1
October 15th 2007WHITEHOUSE STATION, N.J. -- The FDA has approved raltegravir (Isentress) as part of a combination regiment for treatment for multi-resistant HIV-1 infection in adults, according to an announcement from Merck.
Extra Antibiotics Provide Only Transient Improvement in Lyme Encephalopathy
October 11th 2007NEW YORK -- If standard intravenous antibiotics don't relieve persistent or recurrent memory deficits in Lyme encephalopathy, a 10-day IV course of ceftriaxone (Rocephin) may do so -- but the benefit doesn't last.
IDSA: Rotavirus Infection, Not Just for Kids
October 11th 2007SAN DIEGO -- Rotavirus infection, once considered almost exclusively a pediatric diarrheal disease, affects adults as well, causing substantial morbidity and unnecessary use of procedures and antibiotics, according to results of a study reported here.
Does Stress Cause Disease? It Doesn't Help, Reviewers Say
October 10th 2007PITTSBURGH -- There is strong evidence suggesting -- but not proving -- the existence of a causal link between psychological stress and chronic conditions such as depression, cardiovascular disease, and HIV/AIDS, asserted researchers here.
IDSA: New HBV Vaccine Tops Conventional One in Older Adults
October 9th 2007SAN DIEGO -- A vaccine created from hepatitis B surface antigen linked to an immunostimulant led to more rapid and durable immune responses and greater seroprotection in older patients compared with the conventional vaccine, according to results of a phase III trial reported here.
IDSA: Neurologic and Psychiatric Problems Common Years after Perinatal HIV Infection
October 8th 2007SAN DIEGO -- Adolescents and teenagers with perinatally acquired HIV infection have high rates of neurologic, psychiatric, and cognitive problems that can confound attempts to treat them, investigators reported here.